Condition

Female Breast Carcinoma

ClinicalTrials.gov condition label

Clinical trials6

Recruiting0

Common interventions8

Lead sponsors shown6

Clinical trials

6 shown

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerNCT02942355 · 2016-12-07

ACTIVE_NOT_RECRUITING

A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantNCT02540330 · 2016-03-01

Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or ChemotherapyNCT02243163 · 2014-05-01

Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for MammographyNCT04290585 · 2014-03-05

Anesthesia and Circulating Tumor Cells in Breast CancerNCT02005770 · 2014-03-01

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast CancerNCT01643148 · 2011-01-01

Common interventions

anastrozoleDRUG1 FulvestrantDRUG1 PalbociclibDRUG1 PropofolDRUG1 Questionnaire AdministrationOTHER1 SevofluraneDRUG1 Telephone-Based InterventionBEHAVIORAL1 Yoga exerciseBEHAVIORAL1

Leading sponsors

Atossa Therapeutics, Inc.1 Chang Bing Show Chwan Memorial Hospital1 Fox Chase Cancer Center1 Materno-Perinatal Hospital of the State of Mexico1 University of Zurich1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

NA2

PHASE22

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.